The Lean Startup Model for Healthcare


The Presentation inside:

Slide 0

The Lean Startup Model for Healthcare Day 2, 5th November 2015, Morning session 10.00am-10.30am Matrix Level 4, Breakthrough+Discovery Theatres Hugh Mason, Co-founder and CEO, JFDI.Asia [email protected] @hughmason 79 Ayer Rajah Crescent #03-01 Singapore 139995 With thanks to: JFDI Clients & Colleagues, Stuart Smith and Alex Danco for inspiration. This presentation includes numerous borrowed graphics, to which I hope I have included attribution. If not my apologies - please allow me to correct any omissions


Slide 1

Coming Up Introducing JFDI Why Lean Startup Matters for Healthcare How Lean Startup Does and Doesn’t Work What are Some Opportunities for Singapore? Suggestion: Q&A at panel 10:45


Slide 2


Slide 3


Slide 4

First ASEAN startup accelerator, backed by IIPL, Fenox VC, Family Offices, HNWI’s Accelerator has attracted over 2,000 startup teams from 80+ countries. Pre-Accelerator has supported 250 teams comprising 900 people via MOOC USD2m pre-seed capital deployed into 69 startups, >50% raised median USD550k No exits yet but 48% IRR (unrealized). Over 300 jobs created, >50% of which are in Singapore and >50% filled by SCPRs. Team of 16 split Singapore-Philippines. Pioneered Lean Startup and disciplined entrepreneurship methods in Asia JFDI.Asia


Slide 5


Slide 6

1 Why Lean Startup Matters for Healthcare


Slide 7

Macrotrend 1 - Demographics


Slide 8

Macrotrend 2 - 42% of internet users are in Asia


Slide 9

Macrotrend 3 - Weightless Giants


Slide 10

Macrotrend 4 - The Service Dominant Mindset


Slide 11

Macrotrend 5 - Unbundling


Slide 12

Macrotrend 6 - New Innovation Frameworks “Plan & Perfect v. Launch & Learn”


Slide 13

“Plan & Perfect” - Vision Based Innovation


Slide 14

“Launch & Learn v. Plan & Perfect”


Slide 15

“Launch & Learn v. Plan & Perfect” Discovery Based Innovation “Launch & Learn” - Discovery Based Innovation Design Thinking Lean Startup Agile Methods


Slide 16

Problem Customer Discovery Problem- Solution Fit Market- Solution Fit Individuals Teams Problem Statement Minimum Viable Prototype Traction Seed Stage Startup Series A Stage SME Startup Weekends, Hackathons Product Development Customer Discovery Growth Hacking Demo Day “A startup is a temporary organization designed to search for a repeatable and scalable business model” - Steve Blank


Slide 17

Two of the Risks in Innovation Market Risk- Should it be done? Technology Risk - Could it be done? LOW HIGH HIGH


Slide 18

Business Model Innovation Market Risk- Should it be done? Technology Risk - Could it be done? LOW HIGH HIGH


Slide 19

Market Risk- Should it be done? Technology Risk - Could it be done? LOW HIGH HIGH Tech2Market - Vision Driven


Slide 20

Market Risk- Should it be done? Technology Risk - Could it be done? LOW HIGH HIGH Tech2Market - Vision Driven “Teams that pursued traditional methods of starting a company had an 18% success rate in receiving SBIR Phase I funding” (Blank 2013)


Slide 21

Market Risk- Should it be done? Technology Risk - Could it be done? LOW HIGH HIGH Market2Tech - Discovery Driven “Teams that … took the Lean Launchpad class ... had a 60% success rate” (Blank 2013)


Slide 22

2 How Lean Startup Does and Doesn’t Work


Slide 23

“Launch & Learn v. Plan & Perfect”


Slide 24


Slide 25


Slide 26


Slide 27

< Solution < Value Proposition Horses? Faster?


Slide 28

How the 19th Century ‘Bundled’ Mobility


Slide 29

“If I’d asked people what they wanted, they would have said: more hospitals”


Slide 30


Slide 31

3 What are the Opportunities for Singapore?


Slide 32


Slide 33

“The assumption that the pursuit of drugs, diagnostics, devices and digital health is all about the execution of the science is in most cases a mistake.” (Blank 2013)


Slide 34


Slide 35

Conclusions - 1 Healthcare is a business Business model innovation matters as much as science. We can choose how we bundle components of healthcare. New frameworks for innovation let us test critical hypotheses relating to regulation, customers and funding before we commit significant resources to science.


Slide 36

Conclusions - 2 The way forward is to: assess regulatory risk before we design and build. gather data essential to understand customer purchases before we do the science. define clinical utility now, before we spend millions of dollars. identify financing vehicles before we need them.


×

HTML:





Ссылка: